Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atropine in Electroconvulsive Therapy.

Anthony J. Bouckoms1, Charles A. Welch, Lambertus J. Drop

  • 1Massachusetts General Hospital, Boston, Massachusetts, USA.

Convulsive Therapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sensitive Detection of Plasma Fibrinogen Chain A mRNA in Hepatocellular Carcinoma Using Semi-Nested RT-PCR.

Diagnostics (Basel, Switzerland)·2025
Same author

Accurate quantification of cell-free Ceruloplasmin mRNA as a biomarker for early detection of hepatocellular carcinoma.

Scientific reports·2025
Same author

Cardiovascular Effects of ECT.

Convulsive therapy·1989
Same author

Anesthesia for Electroconvulsive Therapy in Patients with Major Cardiovascular Risk Factors.

Convulsive therapy·1989
Same journal

Wilson's disease, psychosis, and ECT.

Convulsive therapy·1998
Same journal

Maintenance electroconvulsive therapy for Parkinson's disease.

Convulsive therapy·1998
Same journal

Multiple ECT late in the course of neuroleptic malignant syndrome.

Convulsive therapy·1998
Same journal

Prejudice against ECT: competition with psychological philosophies as a contribution to its stigma.

Convulsive therapy·1998
Same journal

Quantifying utilization and practice variation of electroconvulsive therapy.

Convulsive therapy·1998
Same journal

Electroconvulsive therapy consultation: an update.

Convulsive therapy·1998
See all related articles

Intravenous atropine given before electroconvulsive therapy (ECT) can benefit patients with cardiac issues like bradycardia. However, it may pose risks for those with hypertension or tachycardia.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) can induce significant cardiovascular changes.
  • Patients with major depression may present with pre-existing cardiac conditions.

Purpose of the Study:

  • To evaluate the effects of intravenous atropine on cardiac function during ECT.
  • To determine the potential benefits and risks of atropine in this patient population.

Main Methods:

  • Nineteen patients with major depression undergoing ECT were alternately administered intravenous atropine or saline before anesthesia.
  • Continuous cardiac monitoring was performed during the procedure.

Main Results:

  • Atropine significantly increased heart rate compared to saline.

Related Experiment Videos

  • Atropine reduced the incidence of dropped beats and premature atrial beats.
  • These effects suggest a potential benefit for patients with hypodynamic cardiac states.

    • Conclusions:

    • Intravenous atropine may be beneficial for ECT patients with bradycardia, bradyarrhythmia, or hypotension.
    • Atropine's increase in cardiac work necessitates caution in patients with hypertension, tachycardia, or risk of cardiac ischemia.